Dapcel Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Dapcel General Information

Description

Provider of experimental protein laboratory services intended to optimize enhanced protein production in any organism. The company's laboratories specialize in providing gene redesign services for enhanced protein expression in heterologous and homologous hosts that take into account the importance of rare codons and overall kinetics of protein translation guided by synonymous codon usage for protein production and co-translational protein folding, enabling research institutes to achieve clinical results.

Contact Information

Website
www.dapcel.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 11000 Cedar Avenue
  • Suite 110
  • Cleveland, OH 44106-3069
  • United States
+1 (216)
Primary Industry
Biotechnology
Corporate Office
  • 11000 Cedar Avenue
  • Suite 110
  • Cleveland, OH 44106-3069
  • United States
+1 (216)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dapcel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view Dapcel’s complete valuation and funding history, request access »

Dapcel Patents

Dapcel Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3365452-A1 Expression in mammalian cells with gaussia luciferase signal peptide Active 23-Oct-2015
EP-3365452-B1 Expression in mammalian cells with gaussia luciferase signal peptide Active 23-Oct-2015
EP-3365452-C0 Expression in mammalian cells with gaussia luciferase signal peptide Active 23-Oct-2015
US-12173036-B2 Expression in mammalian cells with gaussia luciferase signal peptide Active 23-Oct-2015
US-20180319854-A1 Expression in mammalian cells with gaussia luciferase signal peptide Active 23-Oct-2015 C07K14/43509
To view Dapcel’s complete patent history, request access »

Dapcel Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dapcel Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bio, Tech and Beyond Accelerator/Incubator
To view Dapcel’s complete investors history, request access »

Dapcel FAQs

  • When was Dapcel founded?

    Dapcel was founded in 2008.

  • Where is Dapcel headquartered?

    Dapcel is headquartered in Cleveland, OH.

  • What is the size of Dapcel?

    Dapcel has 4 total employees.

  • What industry is Dapcel in?

    Dapcel’s primary industry is Biotechnology.

  • Is Dapcel a private or public company?

    Dapcel is a Private company.

  • What is Dapcel’s current revenue?

    The current revenue for Dapcel is .

  • Who are Dapcel’s investors?

    Bio, Tech and Beyond has invested in Dapcel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process